CAR T Cells: On the Road to Synthetic Immunity
Original lecture date: August 13, 2020

Michel Sadelain, MD, PhD
Director, Center for Cell Engineering
Stephen and Barbara Friedman Chair
Member, Immunology Program
Member, Departments of Medicine and Pediatrics
Memorial Sloan-Kettering Cancer Center